Financial results and reports

We transform medical images into meaningful, actionable insights to help better diagnose, treat, and monitor patients. We deploy proprietary artificial intelligence, computer vision, and signal processing technologies to develop imaging tests and services, addressing life-threatening unmet medical needs.

With eyonis™ we are disrupting the management of serious diseases such as lung cancer and liver cancer. We are deploying AI/ML Software as Medical Devices (SaMDs) to help health professionals diagnose patients earlier, treat them more effectively, and bring new hope. eyonis™ is currently under development.

Imaging Services for Clinical Trials

Median’s Imaging CRO business provides leading oncology clinical trial imaging services, empowering our life sciences partners to accelerate the development and delivery of life-saving cancer treatments with unmatched operational excellence and reliability. And we don’t stop there. We are forging the way when it comes to innovative imaging technology, leveraging the latest in AI-powered imaging intelligence to develop actionable insights for biopharma sponsors worldwide.

Learn More

Request a Demo

10/12/2016

Half year financial report 2016
Download 20161012_HY_financial_results_2016.pdf
04/12/2016

Financial report 2015
Download Financial_report_2015-1.pdf
10/05/2015

Summary half year consolidated financial statements June 30, 2015 – in accordance with IFRS
Download Consolidated_accounts_IFRS_HY12015.pdf

Half year financial report 2016

Financial report 2015

Summary half year consolidated financial statements June 30, 2015 – in accordance with IFRS